GOLDENWELL BIOTECH, INC. financial data

Symbol
GWLL on OTC
Location
Solon, OH
Fiscal year end
31 December
Latest financial report
10-Q - Q2 2025 - 12 Sep 2025

Key Ratios

Label TTM Value / Value Unit Change %
Debt-to-equity -460% % -300%
Return On Equity 153% %
Return On Assets -43% % 37%
Operating Margin -21659% % 56%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 99,000,000 shares 0%
Common Stock, Shares, Outstanding 99,000,000 shares 0%
Entity Public Float $9,600,000 USD -24%
Common Stock, Value, Issued $9,900 USD 0%
Weighted Average Number of Shares Outstanding, Diluted 96,433,333 shares 0%

Income Statement

Label TTM Value / Value Unit Change %
Revenues $0 USD
Revenue from Contract with Customer, Excluding Assessed Tax $557 USD -73%
Cost of Revenue $6 USD -99%
General and Administrative Expense $119,213 USD -11%
Operating Income (Loss) $81,719 USD 39%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest $34,377 USD -11%
Income Tax Expense (Benefit) $0 USD
Net Income (Loss) Attributable to Parent $90,119 USD 34%
Earnings Per Share, Diluted 0 USD/shares

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $25,720 USD
Inventory, Net $174,788 USD 0.06%
Operating Lease, Right-of-Use Asset $0 USD
Assets $251,295 USD 25%
Accounts Payable, Current $0 USD
Liabilities, Current $64,360 USD
Other Liabilities, Noncurrent $189,250 USD
Liabilities $338,133 USD 72%
Retained Earnings (Accumulated Deficit) $1,399,241 USD -6.9%
Stockholders' Equity Attributable to Parent $86,838 USD -2684%
Liabilities and Equity $251,295 USD 25%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $59,380 USD
Net Cash Provided by (Used in) Financing Activities $0 USD -100%
Common Stock, Shares Authorized 300,000,000 shares 0%
Common Stock, Shares, Issued 99,000,000 shares 0%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $76,507 USD 197%
Interest Paid, Excluding Capitalized Interest, Operating Activities $0 USD
Deferred Tax Assets, Valuation Allowance $285,527 USD 11%
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent 0.21 pure 0%
Operating Lease, Liability, Current $0 USD
Lessee, Operating Lease, Liability, Undiscounted Excess Amount $21,565 USD
Deferred Tax Assets, Operating Loss Carryforwards $293,841 USD 6.9%
Additional Paid in Capital $1,302,504 USD 0%
Deferred Tax Assets, Net of Valuation Allowance $0 USD
Interest Expense $2,100 USD 0%